Healthcare data breaches are currently being reported at a rate of more than one a day, according to a new report from the nonprofit Institute for Healthcare IT (IHIT). And for those who think it can’t happen to them, the odds are not in their favor. Breaches reported between 2009 and 2018 have resulted in the theft or exposure of almost 190 million healthcare records, a number equal to 59 percent of the U.S. population, according to the HIPAA Journal.

Boston Scientific Corp. announced the completion of its acquisition of BTG plc. pursuant to the previously announced scheme of arrangement. BTG develops and commercializes products used in minimally invasive procedures targeting cancer and vascular diseases, as well as specialty pharmaceuticals.

HonorHealth Scottsdale Osborn Medical Center is the first hospital in Arizona to begin offering GammaTile Therapy, a new approach to treating recurrent brain tumors. GammaTile Therapy is a U.S. Food and Drug Administration (FDA)-cleared, surgically targeted radiation therapy (STaRT) that is designed to delay tumor regrowth for patients with all types of recurrent brain tumors. The first patient was treated by John Wanebo, M.D., a neurosurgeon and an independent member of the HonorHealth medical staff.

An international team of researchers developed a new magnetic resonance imaging (MRI) technique that can capture an image of a brain thinking by measuring changes in tissue stiffness. The results show that brain function can be tracked on a time scale of 100 milliseconds – 60 times faster than previous methods. The technique could shed new light on altered neuronal activity in brain diseases.

A drug used to treat attention-deficit/hyperactivity disorder (ADHD) appears to affect development of the brain’s signal-carrying white matter in children with the disorder, according to a study published in the journal Radiology.1 The same effects were not found in adults with ADHD.

A drug developed by UCLA physician-scientists and chemists speeds up the regeneration of mouse and human blood stem cells after exposure to radiation. If the results can be replicated in humans, the compound could help people recover quicker from chemotherapy, radiation therapy and bone marrow transplants.

Mevion Medical Systems and C-RAD announced the integration between the C-RAD Catalyst PT and the Mevion S250i proton therapy system. The union of both products supports a seamless workflow with uninterrupted patient surface tracking and monitoring from setup through treatment.

United Imaging announced that its uExplorer total-body positron emission tomography/computed tomography (PET/CT) system is now in use.

August 14, 2019 – Children’s veins are small and sometimes difficult to access during necessary medical treatment. When ...